Blog
The Benefits of Using CE-MS for Bioprocess Optimization and Antibody Therapeutic Characterization
Whether you optimize bioprocesses or enhance the characterization of therapeutic antibodies, CE-MS offers the precision and efficiency required to achieve your goals.
Unlocking Faster Drug Development: The Revolution of Point-of-Need Analysis
Learn how point-of-need analysis is revolutionizing drug development by offering faster, cost-effective, and more efficient processes compared to traditional methods like HPLC.
Exploring the Future of Analytical Technology: At-line Amino Acid Analysis vs. Traditional LC-MS
Learn about an evaluation from the U.S. Federal Drug Administration (FDA) of REBEL’s performance against traditional LC-MS methods.
Devices that Perform at the Speed Scientists Need to Advance Research and Discovery
908 Devices partners and collaborates with world-leading researchers at organizations like NIH, NIBRT and MIT to deliver impactful solutions.
908 Devices Works with Emory University to Revolutionize CAR T-Cell Therapy Manufacturing
CAR T-cell therapy manufacturing is costly. Learn about Emory University’s novel approach methods in an effort to help reduce costs and accessibility.
Lowering Manufacturing Costs and Increasing Accessibility of Cell Therapy Treatments
A robust, fast, and cost-effective production process is crucial for the effectiveness of cell therapy. Our PAT devices help advance cell therapy manufacturing and deliver real-time insights to help get life-saving treatments to patients faster.
National Biotech Month
Biotechnology enables life-saving treatments for millions of people around the world. At 908 Devices, we’re focused on providing scientists analytics at point of need, that provide process insights and accelerate workflows.
The de novo model for 21st century monitoring and control of critical bioprocess parameters
The use of Raman spectroscopy for characterizing critical process parameters (CPPs) and critical quality attributes (CQAs) in bioprocessing has grown considerably during the last 10 years. Learn more about the de novo model for 21st century monitoring and control of critical bioprocess parameters.
MAVEN Analyzer Wins 2023 R&D 100 Award
R&D World magazine announced the 100 winners of the 2023 R&D 100 Awards. 908 Devices’ MAVEN™ was one of the 21 award winners in the Analytical/Test category. Read More.
The Need For Speed In The Lab
The growth and visibility of new biologic-based therapeutics has created a race to see which new medicines can make it to market first. R&D scientists and bioprocess development teams are under immense pressure to meet global demand for new drugs, while at the same time ensuring safety, quality, and cost efficiencies.
Biotech Week Boston 2021 Takeaways
Cooperation, process understanding, and speed are the big takeaways from BPS 2021
email Subscribe to Our Communications Signup to receive new product updates, technical tips and more.